Background: CNS tumors are heterogenous variety of tumors and brain parenchyma is the most common site of CNS tumors, followed by meninges, sellar region and nerves. Meningiomas arise from meningothelial cells of the arachnoid and are attached with the duramater. WHO grading based on the histopathololgical features, alone has limitations in predicting the exact behavior of meningiomas. Hence, the use of immunohistochemical markers like Ki-67 helps in determining the aggressive nature of the tumor and its recurrence potential. To correlate Aim: the signicance of proliferative marker Ki-67 with histological classication and grading of meningiomas cases were taken. Material and Method: A cross-sectional study carried out in the Department of Pathology at Maharaja Agrasen Medical College Agroha, Hisar with sample size of 35 biopsies/excision specimens of meningiomas cases. In the present study, Result: female outnumbered male with female:male ratio of 1.7:1 and mean age of 48 years. Out of 35 cases, 30 cases (85.7%) were of grade I and 5 (14.3%) were of grade II. No case of grade III meningioma was recorded. Mean Ki-67 LI was 6.40±14.21 in grade I and 19.60±12.88 in grade II. So, grade II had signicantly more mean Ki-67 LI compared to grade I and was statistically signicant with p value <0.05. IHC evaluation Conclusion: with Ki-67 LI do add information to the routine histopathological evaluation of meningiomas, and helps in assessing the biological behaviour of meningiomas and in formulating the suitable treatment plan for various grades of meningiomas and follow up of cases as early as possible. So, the use of Ki-67 LI in the histomorphological study of meningiomas is a supplement in determining the histological grade, not a substitute and is of signicance for appropriate management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.